Not ideal, but at least they;re being honest and upfront about it.
...and it doesn't appear to be PYC's tech that was the failing point, but the drug being delivered that didn't meet its end point of efficacy.
- Forums
- ASX - By Stock
- Ann: Conclusion of Genentech Antimicrobial Collaboration
Not ideal, but at least they;re being honest and upfront about...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $676.5M |
Open | High | Low | Value | Volume |
14.0¢ | 14.5¢ | 13.5¢ | $687.7K | 4.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 87494 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 2187900 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 0.140 |
7 | 410503 | 0.135 |
2 | 440000 | 0.130 |
6 | 601814 | 0.125 |
12 | 720407 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 1980000 | 12 |
0.160 | 440336 | 3 |
0.165 | 400000 | 1 |
0.170 | 426000 | 3 |
0.175 | 34000 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online